A field service engineer (fse) conducted a site visit and was able to confirm the out of range quality control (qc) by review of customer controls.The fse checked for leaks within the sampling system and no leaks identified.The fse inspected the substrate syringe and found wear.The fse replaced the substrate syringe and validated the analyzer by running qc with results within acceptable range.The aia-2000 analyzer is functioning as expected.No further action required by field service.The substrate syringe was returned to the tosoh instrument service center and confirmed the wear problem by visual inspection.A 13-month complaint history review and service history review through aware date of event for similar complaints was performed for serial number (b)(6).There were no other similar complaints found during the searched period.The bhcg analyte application manual states the following: limitations of the procedure for diagnostic purposes, the results obtained from this assay should be used in conjunction with other data (e.G., symptoms, results of other tests, clinical impressions, therapy, etc.).Using st aia-pack bhcg, the highest concentration of total beta hcg measurable without dilution is 400 miu/ml, and the lowest measurable concentration is 0.5 miu/ml (assay sensitivity).Although the approximate value of the highest calibrator is 200 miu/ml, the exact concentration may be slightly different.The assay specification, assay range high, should be defined as the upper limit of the assay range, 400 miu/ml.Although hemolysis has an insignificant effect on the assay, hemolyzed samples may indicate mistreatment of a specimen prior to assay and results should be interpreted with caution.Lipemia has an insignificant effect on the assay except in the case of gross lipemia where spatial interference may occur.Specimens from patients who have received preparations of mouse monoclonal antibodies for diagnosis or therapy may contain human anti-mouse antibodies (hama).Such specimens may show falsely elevated values when tested for total beta hcg.Certain medications may interfere with assay performance.Specimens from patients taking medicines and/or medical treatment may show erroneous results.All results should be interpreted with respect to the clinical picture of the patient.For a more complete understanding of the limitations of this procedure, please refer to the specimen collection and handling, warnings and precautions, storage and stability, and procedural notes sections in this insert sheet.The most probable cause of the reported event was due to a wear problem of the substrate syringe, resulting in component failure.
|
A customer reported out of range quality control (qc) result for beta human chorionic gonadotropin (bhcg) on the aia-2000 analyzer.The customer confirmed quarterly maintenance and wash probe maintenance were performed and recalibrated using a new qc, but issue recurred.The analyzer is down.A field service engineer (fse) was dispatched to address the reported event, which resulted in a delayed reporting of patient samples for beta human chorionic gonadotropin (bhcg).There is no indication of any patient intervention or adverse health consequences due to the delay in reporting of patient results.
|